Data protection Impressum

R&D

Lausanne-based Rhonexum, a 2025 spin-off of EPFL, will supply cryogenic integrated circuits to quantum computing company ZuriQ under a multi-year commercial framework agreement.

Rhonexum and ZuriQ sign a multi-year agreement to advance trapped-ion quantum computing

2 November 2026

Built with partners in Zurich and Geneva, spora is a spatial proteomics atlas that EPFL describes as the world's largest freely available collection of its kind, designed to speed up AI research on how diseases develop.

EPFL releases a free tissue atlas to help AI understand cancer

2 November 2026

The Foundation for Innovation and Technology (FIT) is supporting three start-ups working on an osteoporosis treatment, faster tissue analysis during cancer surgery and vineyard monitoring.

Biodelphis Therapeutics, PolaSight and Swiss Soil each receive a CHF 100,000 Tech Seed loan

2 November 2026

In the ESA-supported RESHAPE project, Neuchâtel-based CSEM and Almatech have demonstrated a reusable shock absorber made of 3D-printed shape memory alloy, designed to make future lunar and planetary landers lighter, simpler and more sustainable.

CSEM and Almatech demonstrate a reusable, 3D-printed shock absorber for space landers

2 November 2026

Alcon, the eye care company headquartered in Geneva, has acquired US biotech Neurotech Pharmaceuticals for USD 550 million in cash, plus potential additional payments tied to milestones.

Alcon has acquired Neurotech for USD 550 million

26 October 2026

Sonexos, a deep tech company based in Lausanne, has raised CHF 5 million in a Pre-Series A round led by Valquest Partners with Bosch Ventures, to industrialize its Plasmacoustic Metalayer, a thin plasma layer that absorbs low-frequency noise.

Sonexos raises CHF 5 million to bring plasma-based noise reduction to home appliances

26 October 2026

Switzerland's sports tech sector counts 402 companies, an estimated CHF 8 billion in revenue and about 17,000 jobs, according to the first Swiss SportsTech Report. Vaud and Bern are among the three cantons that concentrate about half of the companies.

First Swiss SportsTech Report maps a CHF 8 billion sector with Vaud and Bern among its main hubs

26 October 2026

Home to many sports federations and organizations, Western Switzerland is a distinctive setting for sports tech companies and start-ups. The first Swiss SportsTech Report counts 402 companies in the country, with Vaud among the three cantons that concentrate about half of them.

Western Switzerland’s unique ecosystem for SportsTech

Orbis Medicines, a drug discovery company with operations in Lausanne and Copenhagen, has entered a multi-target collaboration with Novo Nordisk worth up to USD 1.4 billion to develop oral macrocycle drugs for cardiometabolic diseases.

Orbis Medicines and Novo Nordisk partner in a deal worth up to USD 1.4 billion

21 October 2026

Biopôle-based Legacy Healthcare has received Breakthrough Therapy designation from the U.S. FDA for Cinainu, a topical botanical drug for moderate-to-severe alopecia areata in patients aged two and older.

Legacy Healthcare’s botanical treatment receives FDA Breakthrough Therapy designation

21 October 2026

1 2 3 4 5 … 19